New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 20, 2013
10:46 EDTMAC, PTR, TTM, STT, ALKSHigh option volume stocks: ALKS TTM MAC STT PTR
News For ALKS;TTM;MAC;STT;PTR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
March 2, 2015
08:14 EDTSTTBlackRock, State Street may lose advantage over newer ETF firms, Reuters says
Subscribe for More Information
08:11 EDTALKSAlkermes to hold an analyst and investor meeting
Subscribe for More Information
07:03 EDTALKSAlkermes reports new drug candidate for treatment of depression, other diseases
Subscribe for More Information
February 26, 2015
10:02 EDTSTTState Street appointed by Hartford Funds to assist in providing custody services
State Street announced that it has been appointed by Hartford Funds to assist in providing custody and accounting services for $93.6B in assets under management, which includes $20.6B in mutual funds supporting variable annuity and investment products. Hartford Funds is a leading provider of mutual funds.
10:00 EDTSTTOn The Fly: Analyst Downgrade SummaryStarz
Subscribe for More Information
07:47 EDTSTTState Street downgraded at Credit Suisse
Subscribe for More Information
06:29 EDTSTTState Street downgraded to Neutral from Outperform at Credit Suisse
06:15 EDTSTTState Street downgraded to Neutral from Buy at Citigroup
Subscribe for More Information
February 25, 2015
08:30 EDTALKSAlkermes price target raised to $79 from $75 at Leerink
Leerink raised its price target for Alkermes shares to $79 to reflect probability-of-success weighted ALKS 8700 in multiple sclerosis revenue. The firm views the company's Q4 results as strong, but notes its 2015 outlook missed consensus due to higher than expected operating expenses. Leerink says the 2015 guidance reflects Alkermes' maturing pipeline. It keeps an Outperform rating on the stock.
06:19 EDTALKSAlkermes pipeline eases loss of pain program, says Citigroup
Citigroup says Alkermes' pipeline programs and the continued growth of its base business help moderate the disappointment of the discontinuation of novel pain program ALKS-7106. Citi lowered its price target for Alkermes shares to $83 from $85 and keeps a Buy rating on the stock.
05:57 EDTALKSUBS says remain on sidelines with respect to Alkermes
Subscribe for More Information
February 24, 2015
10:06 EDTALKSHigh option volume stocks
High option volume stocks: CHGG LBTYK SMH RCAP NGLS OTEX TERP CNC ALKS AMT
08:56 EDTALKSOn The Fly: Pre-market Movers
Subscribe for More Information
08:54 EDTALKSAlkermes 7106 halt overshadows Q4 beat, says Credit Suisse
Subscribe for More Information
07:06 EDTALKSAlkermes sees FY15 adjusted EPS 27c-40c, consensus 20c
Subscribe for More Information
07:03 EDTALKSAlkermes reports Q4 EPS 11c, consensus 4c
Subscribe for More Information
07:01 EDTALKSAlkermes announces phase 1 results for ALKS 7106, will not proceed to phase 2
Subscribe for More Information
February 23, 2015
09:35 EDTSTTState Street to hold analyst and investor day
Analyst and Investor Day to be held on February 25 at 12:30 pm. Webcast Link
February 20, 2015
16:40 EDTSTTState Street says legal accrual does not affect Q4, FY14 results
The increased legal accrual does not affect State Streetís previously announced operating-basis Q4 and FY14 financial results, which are not presented on a GAAP-basis.
16:39 EDTSTTState Street increases Q4 legal accrual to $115M
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use